Left Menu
Development News Edition

Glenmark Appoints Dr. Yasir Rawjee as Chief Executive Officer of Glenmark Life Sciences, its Subsidiary for the API Business

PTI | Mumbai | Updated: 07-05-2019 10:42 IST | Created: 07-05-2019 10:42 IST
Glenmark Appoints Dr. Yasir Rawjee as Chief Executive Officer of Glenmark Life Sciences, its Subsidiary for the API Business

MUMBAI, May 7, 2019/PRNewswire/ --

Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, today announced that it has appointed Dr. Yasir Rawjee as the Chief Executive Officer of Glenmark Life Sciences Ltd., its subsidiary for the API (Active Pharmaceuticals Ingredients) business.

(Logo: http://mma.prnewswire.com/media/451507/PRNE_Glenmark_Logo.jpg )

Yasir joins Glenmark Life Sciences from Mylan Inc., where most recently, he was the Head of Global API Operations. He has held positions of increasing responsibility at Mylan including Senior Vice President of API Technical Operations and Senior Vice President and Head for Sales and Marketing for the API Business. Yasir started his career with SmithKline Beecham Pharmaceuticals based in the USA and has been associated with GlaxoSmithKline and Matrix Laboratories Ltd. previously. He has over 25 years of experience in the pharmaceutical industry. He has a Ph.D. in Chemistry from Texas A&M University, USA and holds a degree in B.Sc.(Tech.) from UDCT Mumbai, India.

Glenmark's API business has witnessed robust growth rate of 15% CAGR over the last 5 years while maintaining its leadership position globally across several molecules. To provide a strategic focus to this business, Glenmark had earlier this year transferred the API business to a wholly-owned subsidiary Glenmark Life Sciences.

"We see significant growth potential in our API business given the increasing demand for good quality and sustained supply of APIs globally. With this view, we housed our API business into a separate subsidiary, which will be run independently. We are happy that Dr. Yasir Rawjee will now spearhead the API unit and take it to greater heights with his rich experience both in the technical and marketing aspects of the business," said Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals.

"Glenmark Life Sciences has built strong partnerships across the globe and has a very focused approach to further expand the API business. I am pleased to join the organization at a time when I believe I am getting an opportunity to contribute meaningfully in scaling up and shaping the next leg of growth for the API unit," said Dr. Yasir Rawjee.

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical organization. It is ranked among the top 75 Pharma & Biotech companies of the world in terms of revenue (SCRIP 100 Rankings published in the year 2018). Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is focused in the areas of oncology, dermatology and respiratory.

The company has a significant presence in the branded generics markets across emerging economies including India. Glenmark has 16 manufacturing facilities across five countries and has six R&D centers. The Generics business of Glenmark services the requirements of the US and Western European markets. The API business sells its products in over 80 countries, including the US, various countries in the EU, South America and India.

Source: Glenmark Pharmaceuticals PWR PWR


TRENDING

OPINION / BLOG / INTERVIEW

Why COVID-19 is unstoppable in USA despite it being ranked at the top of GHS Index?

Several worst-hit countries such as Italy, France, Spain, the UK, Canada, and Russia have peaked COVID-19 cases in April. Almost all of them have gradually flattened the curve. However, the USA is setting new daily records of infections tha...

COVID-19 seems cooking biggest ever global scam

The increasing number of corruption cases on COVID-19 funds from throughout the world and involvement of high profile persons indicate that the countries cant ignore corruption in their pandemic response programs. This has generated the nee...

Health Management Information Systems lack holistic, integrated, and pandemic resilient character

Being a part of the United Nations system, the World Health Organization WHO deserves its share of rebuke for its alleged failure issue COVID-19 health emergency alerts on appropriate time. However, the pandemic has also exposed loopholes i...

Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...

Videos

Latest News

Hong Kong leader says pro-democracy 'protest' vote might have violated new security laws

Hong Kong leader Carrie Lam said on Monday that an unofficial city-wide election conducted by the pro-democracy camp over the weekend might have violated new national security laws by subverting state power.The weekend election drew more th...

Non-stop 'yagna' in Kolkata till Bachchan family recover from COVID-19

Fans of Amitabh Bachchan in Kolkata have organised mahamritunjay yagna, which they said would continue till the Bollywood superstar and his family recover from COVID-19. The prayers, which have been going on round the clock since Sunday mor...

UK retailer Quiz suspends ties with supplier over wage allegations

British fashion retailer Quiz said on Monday it had suspended ties with a supplier accused in a weekend newspaper report of breaching minimum wage requirements at a factory in Leicester, central England.The Times reported on Saturday that w...

CBSE Class 12 results: Marginal dip in pass percentage of foreign schools

The Class 12 pass percentage of foreign schools affiliated to the Central Board of Secondary Education saw a marginal dip this year, according to officials. While the Class 12 pass percentage last year was 95.43 per cent, it was 94.26 per c...

Give Feedback